Background
Cytomegalovirus (CMV) is a prevalent beta-herpesvirus that persists asymptomatically in immunocompetent hosts. More than 90% of people with HIV are co-infected with CMV. During long-term ART, HIV-1/CMV-coinfection is associated with inflammatory-related co-morbidities and persistence of the HIV-1 reservoir, yet the precise degree to which CMV contributes to these pathologies remains unclear.
Methods
We utilized specific pathogen-free rhesus macaques (RMs) that are seronegative for rhesus CMV (RhCMV) throughout life. Adult RhCMV- RMs (n=8) were age and gender matched to animals that naturally acquired RhCMV in early life (n=10) through co-housing. Animals were infected intravenously with 5000IU SIVmac239M and after 28 days received daily suppressive ART for 2 years. Plasma RNA and cell-associated SIV DNA were quantitated by PCR, and immunophenotype by flow cytometry was assessed in blood, lymph node (LN), and gut tissues at baseline and acute SIV (14dpi).
Results
Overall, natural coinfection with RhCMV led to a more severe SIV burden. RhCMV+ RMs had higher peak viremia (p=0.016), and near log-fold increases in seeding of SIV DNA at 14dpi in the colon and duodenum (p<0.0001, p=0.0008, respectively; Fig. A). RhCMV+SIV+ RMs took significantly longer to fully suppress viremia following ART initiation (p=0.031). At 14dpi, RhCMV+SIV+ animals exhibited higher frequencies of activated (CD169+) monocytes in blood (p=0.003) and HLA-DR+CD4+ T-cells in LNs (p=0.033). Prior to SIV, RhCMV+ RMs had higher percentages of CCR5+CD4+ memory T-cells in the blood (p=0.012), LN (p=0.0014), and colon (p=0.01), suggesting that RhCMV systemically increases SIV target cells (Fig. B). At baseline, target cell frequencies in LNs, but not other anatomical sites, were associated with higher peak viremia (p=0.0016, R=0.673). Notably, in RhCMV+ RMs, most CCR5+CD4+ T-cells did not respond to an RhCMV lysate ex vivo (p=0.002), suggesting target cell expansion by antigen-independent mechanisms. We also observed that HIV-CMV+ human donors (n=6) exhibited higher CCR5 expression on terminal effector memory CD4+ T-cells when compared to those of HIV-CMV- donors (n=6; p=0.041).
Conclusions
RhCMV exacerbates SIV burden, and this is associated with body-wide expansion of CCR5+ target cells, most of which do not react to RhCMV peptides. RhCMV may promote seeding of the SIV reservoir in a diverse array of CD4+ clonotypes. Targeting CMV may be therapeutic during periods of active reservoir seeding.